rural and remote health

[1] Status of coverage of MR vaccination, after supplementary immunization activities in a rural area of South India: a rapid immunization coverage survey.

[2] Differential improvement among countries in child stunting is associated with long-term development and specific interventions

[3] Evaluation of the protective efficacy of reshaped human monoclonal antibody RSHZ19 against respiratory syncytial virus in cotton rats

[4] Advice for travelers

[5] Passive transfer of respiratory syncytial virus (RSV) antiserum suppresses the immune response to the RSV fusion (F) and large (G) glycoproteins expressed by recombinant vaccinia viruses

[6] Immunological responses to monoassociated Bifidobacterium longum and their relation to prevention of bacterial invasion

[7] Women's involvement in household decision-making and strengthening social capital-crucial factors for child survival in Ethiopia

[8] Immunity and immunopathology to respiratory syncytial virus. The mouse model

[9] Influence of moderate malnutrition on morbidity and antibody response following vaccination with live, attenuated measles virus vaccine

[10] Recombinant human respiratory syncytial virus (RSV) monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of RSV-infected mice

[11] Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus

[12] Studies of passive immunotherapy for infections of respiratory syncytial virus in the respiratory tract of a primate model

[13] Response to measles vaccine in Haitian infants 6 to 12 months old. Influence of maternal antibodies, malnutrition, and concurrent illnesses

[14] Lymphocyte subpopulations and antibody levels in immunized malnourished children

[15] Advice for travelers

[16] Development of impaired cell-mediated immunity in mild and moderate malnutrition

[17] Protein supplementation and enhanced antibody-producing capacity in New Guinean school-children

[18] Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus

[19] Immunopathologic mechanisms in lower respiratory tract disease of infants due to respiratory syncytial virus

[20] Advice for travelers

[21] Advice for travelers

[22] Murine cytotoxic T cells specific to respiratory syncytial virus recognize different antigenic subtypes of the virus

[23] Immunoglobulin administration and ribavirin therapy: efficacy in respiratory syncytial virus infection of the cotton rat

[24] Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat

[25] Immune responses to measles and tetanus vaccines among Kenyan human immunodeficiency virus type 1 (HIV-1)-infected children pre- and post-highly active antiretroviral therapy and revaccination

[26] Antigenicity testing of plain and aluminium hydroxide-adsorbed whole-cell cholera vaccines

[27] Factors affecting the infant antibody response to measles immunisation in Entebbe-Uganda

[28] Immunoprophylaxis and immunotherapy of respiratory syncytial virus-infected mice with respiratory syncytial virus-specific immune serum

[29] Immunization against measles in children at risk for severe disease

[30] Measles antibody responses after early two dose trials in Guinea-Bissau with Edmonston-Zagreb and Schwarz standard-titre measles vaccine: better antibody increase from booster dose of the Edmonston-Zagreb vaccine

[31] Clearance of persistent respiratory syncytial virus infections in immunodeficient mice following transfer of primed T cells

[32] Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactiva ted virus

[33] Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group

[34] Immunoprophylaxis of respiratory syncytial virus infection in the infant ferret

[35] mx bio adjuvant for enhancing immune responses against influenza virus

[36] A simplified general method for cluster-sample surveys of health in developing countries

[37] Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine

[38] Acute peripheral neuropathy in adults. Guillain-Barré syndrome and related disorders

[39] Isolation of IgGT from hyperimmune horse anti-snake venom serum: its protective ability

[40] Hybrid plasmacytoma production: fusions with adult spleen cells, monoclonal spleen fragments, neonatal spleen cells and human spleen cells

[41] Hypothermia is not neuroprotective after infection-sensitized neonatal hypoxic-ischemic brain injury

[42] Nursing home-acquired pneumonia

[43] Full Immunization Coverage and Associated Factors among Children Aged 12-23 Months in a Hard-to-Reach Areas of Ethiopia

[44] A Scoping Review of Investment Cases for Vaccines and Immunization Programs.

[45] Chitosan nano-structure loaded with recombinant E. coli O157:H7 antigens as a vaccine candidate can effectively increase immunization capacity

[46] Socio-demographic determinants of childhood immunization coverage in rural population of Bhojpur district of Bihar, India.

[47] Evaluation of the adverse events following immunization surveillance system in Guruve district, Mashonaland Central 2017.

[48] Electronic Immunization Registries in Tanzania and Zambia: Shaping a Minimum Viable Product for Scaled Solutions.

[49] A study of hepatitis A virus seropositivity among children aged between 1 and 5 years of age: Implications for universal immunization.

[50] Lessons from a training needs assessment to strengthen the capacity of routine immunization service providers in Nigeria.

[51] Understanding the policy environment for immunization supply chains: Lessons learned from landscape analyses in Uganda and Senegal.

[52] Advances in nanomedical applications: diagnostic, therapeutic, immunization, and vaccine production.

[53] Operationalizing Integrated Immunization and Family Planning Services in Rural Liberia: Lessons Learned From Evaluating Service Quality and Utilization.

[54] Perceptions of the usefulness of external support to immunization coverage in Chad: an analysis of the GAVI-Alliance cash-based support.

[55] A missed opportunity: birth registration coverage is lagging behind Bacillus Calmette-Guérin (BCG) immunization coverage and maternal health services utilization in low- and lower middle-income countries.

[56] Assessing barriers and increasing use of immunization information systems in independent community pharmacies: Study protocol for a randomized controlled trial.

[57] Preformulation Characterization and Stability Assessments of Secretory IgA Monoclonal Antibodies as Potential Candidates for Passive Immunization by Oral Administration.

[58] Factors affecting the immunization approaches of caregivers: An example of a teaching and research hospital

[59] Funding gap for immunization across 94 low- and middle-income countries

[60] Maternal reasons for non-receipt of valid Hepatitis B birth dose among mother-infant pairs attending routine immunization clinics, South-east, Nigeria.

[61] Unintended pregnancy and its impact on childhood rotavirus immunization in Peru.

[62] Does improving maternal knowledge of vaccines impact infant immunization rates? A community-based randomized-controlled trial in Karachi, Pakistan

[63] Prevention of tuberculosis in macaques after intravenous BCG immunization.

[64] Status of coverage of MR vaccination, after supplementary immunization activities in a rural area of South India: a rapid immunization coverage survey.

[65] Recommending immunizations to adolescents in Turkey: a study of the knowledge, attitude, and practices of physicians.

[66] Partnering with parents to remove barriers and improve influenza immunization rates for young children.

[67] An assessment of parents' childhood immunization beliefs, intentions, and behaviors using a smartphone panel.

[68] Sequential Immunizations with heterosubtypic virus-like particles elicit cross protection against divergent influenza A viruses in mice

[69] VACCINE IMMUNIZATION FOR PREVENTION OF PNEUMOCOCCAL, HAEMOPHILUS INFLUENZAE AND FLU AMONG SICKLY CHILDREN, WHO OFTEN SUFFER FROM PERSISTENT HETEROSPECIFIC INFECTIOUS PATHOLOGY OF THE BRONCHOPULMONARY SYSTEM

[70] Vascular consequences of passive Aβ immunization for Alzheimer's disease. Is avoidance of "malactivation" of microglia enough?

[71] Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2019-20 Influenza Season.

[72] Is antibody titer useful to verify the immunization after VZV Vaccine in MS patients treated with Fingolimod? A case series

[73] Routine childhood immunization may protect against COVID-19

[74] Avoidance of Self during CRISPR Immunization.

[75] Feasible Improvements in Vaccines in the Expanded Programme on Immunization

[76] The effect of a vaccination program on child anthropometry: evidence from India's Universal Immunization Program

[77] General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP)

[78] Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine

[79] Pneumococcal conjugate vaccine for childhood immunization--WHO position paper

[80] Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3-6 months after immunization

[81] Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus

[82] Challenges in global immunization and the Global Immunization Vision and Strategy 2006-2015

[83] The effect of a vaccination program on child anthropometry: evidence from India's Universal Immunization Program

[84] The impact of helminths on the response to immunization and on the incidence of infection and disease in childhood in Uganda: design of a randomized, double-blind, placebo-controlled, factorial trial of deworming interventions delivered in pregnancy and early childhood [ISRCTN32849447]

[85] The impact of helminths on the response to immunization and on the incidence of infection and disease in childhood in Uganda: design of a randomized, double-blind, placebo-controlled, factorial trial of deworming interventions delivered in pregnancy and early childhood [ISRCTN32849447]

[86] Malnutrition and seroconversion following measles immunization

[87] Benefit versus risk factors in cholera and typhoid immunization

[88] Benefit versus risk factors in cholera and typhoid immunization.

[89] Malnutrition and Seroconversion Following Measles Immunization

[90] Haemophilus influenzae Disease and Immunization in Developing Countries

[91] a study of universal immunization coverage during last five years in resettlement colonies of delhi

[92] how supportive supervision influences immunization session site practices: a quasi-experimental study in odisha, india

[93] hepatitis b virus vaccination of voluntary blood donors and immunization status assessment by anti-hepatitis b surface (hbs) antibody titer

[94] antibody responses in mice after immunization with inactivated bovine respiratory syncytial virus using different adjuvants respostas de anticorpos em camundongos após imunização com vírus respiratório sincicial bovino inativado utilizando diferentes adjuvantes

[95] conjugated pneumococcal vaccine for immunization of children — who recommendations

[96] intranasal immunization with influenza virus-like particles containing membrane-anchored cholera toxin b or ricin toxin b enhances adaptive immune responses and protection against an antigenically distinct virus

[97] antenatal and neonatal visits increase complete immunization status among children aged 12-23 months in rural area of indonesia

[98] centrality measures for immunization of weighted networks

[99] kap study on immunization of children in a city of north india – a 30 cluster survey

[100] canada’s national advisory committee on immunization: celebrating 50 years

[101] current challenges and achievements in maternal immunization research